Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

Contributed by: Business Wire

Logo

Tags

Medical Devices

Finance

Clinical Trials

Professional Services

Biotechnology

Other Health

Health

Pharmaceutical

Oncology

Summit Partners

More Like This

Diapath’s equipment portfolio, which includes tissue processors, stainers, embedding centers, and microtomes, is underpinned by its innovative development process and cutting-edge Italian design and quality, resulting in a differentiated product set that resonates with customers. (Photo: Business Wire)

StatLab Medical Products Signs Definitive Agreement With Diapath

PR Newswire associated0

Leica Biosystems Unveils Next-Gen Pathology Portfolio at ECDP 2025

Top-rated US health system expands Sectra's enterprise imaging solution with digital pathology to enhance collaboration for improved cancer care

Three French healthcare providers digitize pathology with Sectra to enhance collaboration and cancer diagnostics

One of the largest multi-region healthcare systems in the US expands enterprise imaging cloud service from Sectra with pathology to leverage integrated diagnostics in cancer care

StatLab Empowers Growth in Key European Countries through Direct Market Expansions in Germany and France

Michigan Medicine harnesses the power of Sectra's digital pathology solution to enhance patient care and foster collaboration among physicians

PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe